|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.42%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.42%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
0.42%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
MEDP
|
Medpace Holdings, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
0.40%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
GRFS
|
Grifols, S.A.
|
0.36%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
0.36%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.35%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.35%
|
US
|
NASDAQ
|
|
KOD
|
Kodiak Sciences Inc
|
0.35%
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
0.33%
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.32%
|
US
|
NASDAQ
|
|
CCXI
|
ChemoCentryx, Inc.
|
0.31%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
0.31%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.26%
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
0.26%
|
US
|
NASDAQ
|